IO Biotech CEO a panelist at Cancer Progress Conference
CEO of IO Biotech, Mai-Britt Zocca, will be sitting at the Immuno-Oncology I: Attacking Cancer Antigens – Exploiting Off-the-Shelf And Personalized Vaccines and Triggering of Immunogenic Cell Death panel for the 27th Annual Cancer Progress Conference, in New York City on March 8-9, 2016.
Organized by Defined Health, the event is considered the premier cancer conference for industry leaders. Dr. Zocca has been invited to bring her significant insight in to translational and clinical immune oncology to the professional team of specialists who will be discussing novel approaches in cancer vaccines and the current immune-oncology landscape in general.
Read more about the conference here.